Shopping? Check out our latest product comparisons

Tumor

The 3D high clarity image of melanoma produced using the new imaging technique

Even though melanoma is one of the less common types of skin cancer, it accounts for the majority of skin cancer deaths – around 75 percent. The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence. So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining “clean margins” all around the tumor. So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery – until now.  Read More

Johns Hopkins researchers are testing an infrared scanning system to detect melanoma (Imag...

Although melanoma is one of the less common types of skin cancer, it is responsible for the majority (around 75 percent) of skin cancer related deaths. Part of the problem is that current diagnoses rely on subjective clues such as size, shape and coloring of a mole. With the aim of providing an objective measurement as to whether a lesion may be malignant, researchers at John Hopkins University have developed a prototype non-invasive infrared scanning system that works by looking for the tiny temperature difference between healthy tissue and a growing tumor.  Read More

Researchers at the Yale School of Medicine hope that by eliminaing certain stem cells with...

The medical profession has experienced much difficulty and frustration in detecting and treating ovarian cancer, but researchers at the Yale School of Medicine, Connecticut, believe they have made a major breakthrough. They say eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments.  Read More

After 24 hours, the cancer cells have taken up chimeric polypeptide-chemo combination (sho...

Blood vessels that supply tumors are more porous than normal vessels, makes nanoscale drug delivery systems a particularly attractive prospect. If properly engineered, nanoparticles can in fact get inside a tumor, targeting it precisely and allowing much higher drug dosages as they reduce side effects to a minimum. Two recent studies featured in the latest issue of the journal Nature Materials specifically address these issues and give us promising leads in the fight against cancer.  Read More

The IsoFlow Isolation Catheter in action.

A Silicon Valley entrepreneur, after watching helplessly through his sister's painful and terminal battle with cancer, has spent the last 9 years working on a system that lets doctors cut off blood flow to tumors, isolating them from the rest of the body and allowing the injection of a targeted dose of high intensity chemotherapy. Since the chemo drugs aren't let loose around the rest of the body, the usual devastating side-effects aren't an issue - and the drug dosage at the tumor site can be safely administered at a much higher concentration than usual. The IsoFlow Isolation Catheter has just received FDA marketing approval in the USA.  Read More

A mouse brain tumor imaged using nanoparticles (left) compared to conventional techniques ...

Nanotechnology is preoccupying science to the point where it's starting to seem unremarkable. But a group of researchers from the University of Washington has released findings that could profoundly improve the chances of surviving brain cancer. The team has developed a fluorescent nanoparticle that is capable of penetrating – for the first time – the blood-brain barrier without damaging it. The fluoro nanoparticle targets tumors using a derivative of scorpion venom and enables precise imaging of the size and location of cancerous growths. When the particles meet the tumor, they light up like Christmas.  Read More

Looking for something? Search our 28,158 articles